• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Cure Brain Cancer supports brain cancer immunotherapy trials

Bioengineer by Bioengineer
November 21, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Walter and Eliza Hall Institute, Australia

Our research into new treatments for brain cancer has been boosted by fellowship funding from Cure Brain Cancer Foundation.

A three-year fellowship will support Dr Ryan Cross to translate his research into harnessing immune cells to fight brain cancer, a field known as 'cancer immunotherapy'.

Brain cancer: a deadly disease

More than 1600 new cases of brain cancer are diagnosed in Australia each year. Brain cancer is the leading cause of cancer-related deaths in adults under 40. Cancer can originate in many different cell types in the brain, giving rise to various forms of brain cancer.

Dr Cross said brain cancer also caused more deaths in Australian children than any other disease.

"In the past 30 years patient survival hasn't improved for either adults or children with aggressive brain cancer, despite dramatic improvements in treatments for many other cancers," Dr Cross said.

Improving brain cancer treatments

Dr Ryan Cross has received a Cure Brain Cancer Foundation Early Career Fellowship of $345,000 over three years to fund his research.

Dr Cross, who works with Institute laboratory head Dr Misty Jenkins, said his research focused on two of the deadliest types of brain cancer, diffuse intrinsic pontine glioma (DIPG) – the most aggressive form of brain cancer in children – and adult glioblastoma.

"This work will use patient samples to discover how best to program cancer-fighting immune T cells in the lab to kill brain cancer. This fellowship will enable me to test and refine this approach, developing a 'pipeline' that could allow personalised treatments for children and adults with brain cancer," Dr Cross said.

"An exciting aspect of this work is that everything we do is aiming to initiate clinical trials, which will test whether the cancer-fighting immune T cells we generate are an effective treatment for brain cancer when given to patients."

Collaborative research

Dr Cross said his research was made possible by partnerships with industry, as well as with other scientific and clinical organisations within the Victorian Comprehensive Cancer Centre.

"This work was initiated using seed funding that I received from The Jack Brockhoff Foundation, and now Cure Brain Cancer Foundation have provided me with vital support to continue my research to try and help children with brain cancer."

"I would also like to acknowledge the valuable input we have had from Dr Robert de Rose, a research consumer with personal experience of caring for someone with brain cancer," Dr Cross said.

###

Media Contact

Vanessa Solomon
[email protected]
61-475-751-811
@WEHI_research

Home

Original Source

https://www.wehi.edu.au/news/cure-brain-cancer-supports-brain-cancer-immunotherapy-trials

Share14Tweet7Share2ShareShareShare1

Related Posts

blank

Efficient Matrix Solving with Resistive RAM Technology

October 13, 2025

Chemical Dimerization Inhibits GSDMD-Driven Pyroptosis

October 13, 2025

Dana-Farber Leads Phase 3 Trials for Breast, Lung, and Bladder Cancer Unveiled at ESMO Congress 2025

October 13, 2025

Psychedelic 5-HT2A Activation Changes Brain Blood Flow

October 13, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1230 shares
    Share 491 Tweet 307
  • New Study Reveals the Science Behind Exercise and Weight Loss

    103 shares
    Share 41 Tweet 26
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    100 shares
    Share 40 Tweet 25
  • Revolutionizing Optimization: Deep Learning for Complex Systems

    91 shares
    Share 36 Tweet 23

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Efficient Matrix Solving with Resistive RAM Technology

Chemical Dimerization Inhibits GSDMD-Driven Pyroptosis

Dana-Farber Leads Phase 3 Trials for Breast, Lung, and Bladder Cancer Unveiled at ESMO Congress 2025

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 64 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.